Abstract
The immunogenicity and reactogenicity of a recombinant hepatitis B vaccine was evaluated in 792 healthy 12 years olds. Three doses were administered (time 0,1,6 months); blood samples and self administered questionaries on reactogenicity were collected in a 9 month period. At the time of the first vaccine injection anti-HBc was detected in only three (0.37%) of the subjects. A protective antibody titer (>10mIU/ml) was present in 781 (98.6%) at 9 months (Geometric Mean Titer, GMT, 2951mIU/ml). Only mild local reactions and rare general symptoms were noted. These data confirme the safety and efficacy of this vaccination in Italian adolescents.
Original language | English |
---|---|
Pages (from-to) | 131-135 |
Number of pages | 5 |
Journal | Journal of Preventive Medicine and Hygiene |
Volume | 36 |
Issue number | 3-4 |
Publication status | Published - 1995 |
Keywords
- Immunogenicity
- Italy
- Reactogenicity
- Vaccination
- Vital hepatitis B
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health